Publications by authors named "L Arenare"

Claim this Profile
C
CCDC6 immunostaining in conjunction with the Rad51 HRD assay may expand PARPi treatment eligibility in HGSOC patients.
Daniela Criscuolo, Francesco Merolla, Benedetta Pellegrino, Luca Russolillo, Ilaria De Benedictis, Laura Arenare

Cancer Res Commun· December 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patients.
L Arenare, C Porta, D Barberio, S Terzolo, V Zagonel

J Cancer Policy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trial.
M Bartoletti, A Passarelli, A Fagotti, C Andreetta, S Tamberi, L Arenare

ESMO Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour-infiltrating leucocytes as prognostic biomarkers of bevacizumab-treated ovarian cancer patients results from the phase IV MITO16A/MaNGO OV-2 clinical trial.
Eliana Pivetta, Vincenzo Canzonieri, Marina Bagnoli, Paolo Chiodini, Anna Spina, Laura Arenare

NPJ Precis Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of body mass index on survival and surgical outcomes in ovarian cancer: insights from the MITO trials.
Teresa Di Lauro, Ilaria De Benedictis, Paolo Chiodini, Francesco Perrone, Laura Arenare

Int J Gynecol Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis